摘要
目的观察云南白药加珍珠粉口服治疗支气管扩张并发咯血的临床疗效和对患者、临床护理工作的效果影响。方法选择2014年1月～2015年7月对60例支气管扩张并发咯血患者．应用云南白药加珍珠粉口服来代替氨甲苯酸加酚磺乙胺注射液静脉滴注治疗，并与2012年1月～2013年7月的60例应用氨甲苯酸加酚磺乙胺注射液止血治疗的患者进行回顾性对照研究。结果两组治疗方案在患者的住院天数、止血疗效方面比较差异无统计学意义（P〉0．05），但云南白药加珍珠粉口服在减少患者的静脉输液次数和天数，减轻病房护理工作量上差异有统计学意义（P均〈0．01）。结论云南白药加珍珠粉口服治疗支气管扩张并发咯血止血效果肯定，由于减少了总的静脉输液次数、量和天数，增加了患者的舒适感，降低了输液微粒污染对人体的危害风险，同时也大大减轻了病区的治疗工作量。
Objective To observe the clinical effect of Yunnan Baiyao plus pearl powder orally administration in treat- ment of 60 cases of branchiectasis with hemoptysis and its influence on patients and the outcome of clinical practice. Methods 60 patients with branchiectasis with hemoptysis treated in our hospital from January 2014 to July 2015 were selected and orally given Yunnan Baiyao plus pearl powder instead of intravenous drip of aminomethylbenzoic acid plus etamsylate injection. The results were compared with those of another 60 patients treated by aminomethylbenzoic acid plus etamsylate injection from January 2012 to July 2013 for retrospective control study. Results There was no signifi- cant difference in hospital stay and hemostatic effect between two groups （P〉0.05）. However, Yunnan Baiyao plus pearl powder had significant advantages in reducing times and days of venous infusion and lightening the nursing workload （P all〈0.01）. Conclusion Yunnan Baiyao plus pearl powder orally administration has definite effect on branchiectasis with hemoptysis, and can reduce the times and days of venous infusion, improve comfortable feeling of patients, reduce risk of infusion particle pollution, and lighten the nursing workload.
出处
《中国现代医生》
2016年第16期156-159,共4页
China Modern Doctor
基金
浙江省医药卫生科技计划立项项目(2013KYB268)
浙江省绍兴市科技基金资助项目(2013B70075)
关键词
支气管扩张咯血
云南白药
珍珠粉
护理
Branchiectasis with hemoptysis
Yunnan Baiyao
Pearl powder
Clinical observation
Nursing
